Some believe that healthcare should be funded entirely by the state. Others argue that people who can afford to contribute to their own care should do so.

People disagree about how medical services should be paid for. Some think the government must pay for everything, while others believe rich people should pay for their own treatment. In my opinion, the state should provide healthcare for all citizens.

On the one hand, health is not a normal product. A person cannot decide when he will become ill, and serious treatment costs thousands of dollars, which most families do not have. If a poor person cannot pay, he will not go to the doctor early, and later his illness becomes much more serious and much more expensive. A system paid by taxes protects everybody from this situation.

On the other hand, when rich people pay privately, they bring extra money into the health sector. They also do not use the public hospitals, so the queues for other patients become shorter. Furthermore, some people say it is their own money and they should be free to spend it on a better service if they want.

However, there is also a problem with private hospitals. The best doctors often leave the public system because the salary is higher in private clinics, so the quality of public hospitals becomes worse.

In conclusion, I believe that the state should pay for healthcare, because everybody must have the same chance to be treated. Private clinics can exist, but the government must make sure that public hospitals still have enough good doctors.

Opinion divides over whether healthcare should be funded wholly by the state or partly by those who can afford to pay for themselves. I believe universal state funding must form the base of any system, primarily because of how the cost of illness behaves.

Medical need is unpredictable and occasionally enormous. Nobody can forecast a cancer diagnosis or a serious accident, and the resulting bills routinely exceed what an ordinary household could ever save. Risk of that shape can only be handled by pooling it across a whole population, which is precisely what tax funding does. There is a practical consequence too: where people pay at the point of use, they delay seeking help, and conditions that were cheap to treat early become expensive emergencies later, so a system that deters early visits often costs more overall. A single national purchaser also has considerable bargaining power over drug prices, which fragmented private buyers do not.

The argument for allowing private payment is not without force. It introduces additional money into healthcare, patients who go privately are no longer occupying public capacity, and prohibiting people from spending their own income on their own health is difficult to defend in a free society. The difficulty is that private provision does not create doctors; it recruits them from the same limited pool, usually with higher pay. Unless training places expand alongside it, a growing private sector draws experienced clinicians out of public hospitals and the waiting lists it was supposed to relieve grow instead.

In conclusion, I support healthcare funded by the state for everyone, with private care permitted rather than banned. The condition is that it must be regulated and staffed so that it adds capacity to the system rather than transferring it from those who cannot pay.

Arguments about healthcare funding usually collapse two separate questions into one: who pays, and who is permitted to buy more. Keeping them apart makes a clearer answer possible. My position is that funding must be universal and public, while private purchase should be allowed but constrained — and the reason for the constraint is not egalitarian sentiment but arithmetic about the workforce.

The case for public funding rests on the shape of medical risk rather than on fairness. Health costs are unpredictable, highly skewed and occasionally catastrophic: most people spend little in most years, and a small minority incur bills no household could save against. Insurance is the only rational response to that distribution, and voluntary insurance markets handle it badly, because the healthy opt out and premiums rise for those remaining until the people who most need cover are the least able to obtain it. Universal tax funding is simply the most complete form of risk pooling available, and it avoids that spiral by construction. It also confers real purchasing power — a single national buyer negotiates drug prices that fragmented private purchasers cannot.

A second argument is often overlooked. Charging at the point of use does not merely inconvenience patients; it changes when they arrive. Conditions that are cheap to treat early become expensive when presented late, so systems that deter early consultation frequently spend more in total while delivering worse outcomes — an unusual case where the generous option is also the economical one.

The liberty objection nonetheless deserves a serious answer, because it is the strongest thing the other side has: forbidding someone from spending their own money on their own health is a considerable intrusion, and few countries attempt it. The real problem with a private tier is not that it is unfair but that it is not additive. Doctors and nurses take a decade to train, so their supply is fixed in the short run, and a private sector staffed from that pool does not expand capacity — it relocates it, typically towards those who need it least. Where this happens without a matching expansion of training places, the public waiting lists the private sector was meant to relieve lengthen instead. That is a zero-sum outcome dressed as a market solution.

My conclusion is therefore a qualified one on both sides. Healthcare should be funded by the state for everybody, because that is what the structure of medical risk requires. Private care should be permitted, because prohibiting it is illiberal and largely unenforceable — but only alongside a genuine expansion of the workforce, without which a second system does not add care, it merely reallocates it.